Tagged:

Malaria Vaccine R21 'First to Achieve WHO-Specified 75% Efficacy'

Researchers from the University of Oxford and its partners have reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, In their findings, they note that they are the first to meet the World Health Organization's Malaria Vaccine Technology Roadmap goal of a vaccine with at least 75% efficacy - days before World Malaria Day on April 25.

Video

An infant surrounded by a protective mosquito net in Ghana.

InFocus

Don't Miss

AllAfrica publishes around 800 reports a day from more than 130 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.